ReviewCancer management and research2023

Teclistamab for Multiple Myeloma: Clinical Insights and Practical Considerations for a First-in-Class Bispecific Antibody.

Darren Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.